Actuate Therapeutics (ACTU)
Actuate Therapeutics (ACTU) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- ACTU last traded at $0.21 on 2026-11-19, -12.95% for the session.
- Actuate Therapeutics: market cap $5.13M.
- Over the past year ACTU returned -96.35%, with a year-to-date return of -96.51%.